CVS Health Corp (CVS) is slightly overvalued and we do not publish a verdict for Oscar Health Inc (OSCR).
We publish an intrinsic value for CVS but not for OSCR, so the two cannot be ranked on price.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $79.35; the price of $87.10 is 10% above that value, and 82% of that value comes from beyond year five.
Leak Score 36/100 on 9 of 12 signals
We do not publish a value for this company: we do not know how much cash it holds.
Leak Score 59/100 on 3 of 12 signals
| Metric | CVS | OSCR |
|---|---|---|
| Verdict | Slightly overvalued | Not valued |
| Price | $87.10 | $30.67 |
| Intrinsic value | $79.35 | — |
| Margin of safety | -10% | — |
| Leak Score | 36/100 (9/12) | 59/100 (3/12) |
| Market cap | $111.4B | $9.5B |
| Revenue growth, 5 years | 8.4% | 90.8% |
| Operating margin | 3.5% | 4.1% |
| Net margin | 1.2% | 3.6% |
| Return on equity | 6.2% | 34.3% |
| Debt to equity | 0.96 | 0.21 |
| P/E | 23.0x | 22.4x |
| Forward P/E | 10.2x | 13.1x |
| P/B | 1.4x | 4.6x |
| Dividend yield | 3.1% | — |